![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Shao Jimin Liu Xiyong Zhu Lijun Yen Yun
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.17, Iss.12, 2013-12, pp. : 1423-1437
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting Aldose Reductase for the Treatment of Cancer
Current Cancer Drug Targets, Vol. 11, Iss. 5, 2011-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting survivin in cancer therapy
By Pennati Marzia Folini Marco Zaffaroni Nadia
Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 4, 2008-04 ,pp. :